| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |